Berjame, Angelita R.
HRN: 17-64-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/30/2022
06/06/2022
IV
600mg
Q6hrs
Non Healing Wound, Right Foot
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes